🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

RecruitingPhase 2, Phase 3Ages 18 Years - 55 YearsMalePelage Pharmaceuticals, Inc.
NCT07819435 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is designed to validate efficacy and long term safety of PP405.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Males (assigned at birth) aged 18 to 55 years, inclusive at time of consent. 2. Able and willing to provide written informed consent 3. Must have been experiencing Androgenetic Alopecia (AGA) for at least 6 months prior to screening. 4. Have a modified Norwood-Hamilton score of Type IV or Type V 5. Agree to comply with protocol procedures Exclusion Criteria: 1. Concomitant diagnosis of non-AGA forms of alopecia. 2. Use of other hair loss treatments within periods specified in protocol. 3. Use of excluded medications and procedures as specified in protocol. 4. Diagnosis of other medical conditions as specified in protocol. 5. Any disease or medical condition that, in the opinion of the Investigator, would prevent the subject from participating in the study or might confound study results.
💊

What it tests

  • PP405 0.05% Topical Gel
  • Vehicle Topical Gel
📍

Where

63 sites
AllerVie Clinical Research
Birmingham, United States
Cahaba Dermatology & Skin Health Center
Birmingham, United States
Johnson Dermatology
Fort Smith, United States
Burke Pharmaceutical Research
Hot Springs, United States
Northwest Arkansas Clinical Trials Center/Hull Dermatology P.A.
Rogers, United States
First OC Dermatology Research, Inc.
Fountain Valley, United States
Ablon Skin Institute and Research Center
Manhattan Beach, United States
Quest Dermatology Research
Northridge, United States

…and 55 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy